Spectranetics Quick-Cross Extreme Product Line Receives FDA Clearance (Medical News Today)
Spectranetics Corporation (NASDAQ:SPNC) today announced clearance from the Food and Drug Administration for the Quick-Cross Extreme product line, which represents an extension of its Quick-Cross support catheters. The FDA clearance follows the recent receipt of the CE Mark in Europe and approval to market these products in Canada.

FDA Approves Boston Scientific's Express(R) SD Renal Stent System (Medical News Today)
Boston Scientific Corporation (NYSE: BSX) announced that the U.S. Food and Drug Administration (FDA) has approved the Express(R) SD Renal Monorail(R) Premounted Stent System for use as an adjunct to PTRA (percutaneous transluminal renal angioplasty) in certain lesions of the renal arteries.

IMPAX Provides Update On Meeting With FDA To Review Phase III Trial Results For IPX056 (Medical News Today)
IMPAX Laboratories, Inc. announced that it met with representatives of the U.S. Food and Drug Administration (FDA) to review the results of its IPX056 clinical development program and discuss next steps in development leading to submission of a new drug application (NDA).